| Financial Year |
March 31 2023 |
| Monetary Funds |
79,583,736.22 |
| Held-for-trading Financial Assets |
74,018,211.22 |
| Notes Receivable |
-- |
| Accounts Receivable |
35,575,507.30 |
| Advances to Suppliers |
1,279,530.77 |
| Other Receivables |
1,858,186.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
45,676,275.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
19,540,864.57 |
| Total Current Assets |
262,035,039.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
62,204.34 |
| Investment Properties |
64,877,305.06 |
| Fixed Assetes |
95,867,134.19 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
8,029,188.57 |
| R&D expenses |
-- |
| Goodwill |
6,848,289.37 |
| Long-Term Deferred and Prepaid Expenses |
972,781.44 |
| Deferred Income Tax Assets |
1,310.98 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
455,702,016.73 |
| Total Assets |
717,737,056.18 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
10,594,054.46 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,568,061.77 |
| Taxes Payable |
3,470,459.22 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,548,127.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
504,359.82 |
| Other Current Liabilities |
215,507.31 |
| Sub-Total of Current Liabilities |
28,449,384.83 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
343,106.75 |
| Total Liabilities |
28,792,491.58 |
| Paid-In Capital(Or Share Stock) |
336,000,000.00 |
| Capital Surplus |
387,846,154.44 |
| Surplus Reserve |
34,827,796.69 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-75,933,843.85 |
| Minority Stockholder's Interest |
6,204,457.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
682,740,107.28 |
| Owner's Equity（Stockholder's Equity） |
688,944,564.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
717,737,056.18 |
